» Articles » PMID: 27125092

INTRAUTERINE GROWTH RESTRICTION--PREDICTIVE SERUM MARKERS

Overview
Date 2016 Apr 30
PMID 27125092
Authors
Affiliations
Soon will be listed here.
Abstract

Aim: To determine during the first trimester of pregnancy some serum and ultrasound markers that could improve perinatal morbidity and mortality in women with intrauterine growth restriction (IUGR).

Material And Methods: Prospective study of pregnant women gestational age 11 weeks and 0 days--13 weeks and 6 days, consisting in the determination of pregnancy associated plasma protein (PAPP-A), mean platelet volume (MPV), and ultrasound appearance of placenta.

Discussion And Conclusions: This study suggests that screening by detailed history and PAPP-A and MPV determination during the first trimester of pregnancy in women at risk for IUGR makes possible the prophylactic treatment and monitoring of pregnancy according to a given protocol and thus neonatal morbidity and mortality to be reduced.